Additional information
White powder
1443118-73-7
ACI-018216
179.7-181.9°C
C22H20N4OS
388.49
Ambient
2-8°C
Antineoplastic
Pharmaceutical Impurity Standards
N-methyl-2-((3-(2-(pyridin-2-yl)ethyl)-1H-indazol-6-yl)thio)benzamide (Dihydro-Axitinib)
N-methyl-2-((3-(2-(pyridin-2-yl)ethyl)-1H-indazol-6-yl)thio)benzamide
Benzamide, N-methyl-2-[[3-[2-(2-pyridinyl)ethyl]-1H-indazol-6-yl]thio]





![N-METHYL REGADENOSON (25 mg) (1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N,N-dimethylpyrazole-4-carboxamide )](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)
 
                    